Board of Advisors
| 
|
We have a distinguished panel of advisors who provide input and guidance on wide range of topics include industry conditions, market direction, business strategy and sales/marketing guidance. Over the years, we have come to rely on the deep expertise of each and every advisor we have in our panel that strengthens Pilgrim Software which in-turn provides our customers improved customer satisfaction experience.
|
 |
Dr. Francine Décary is a member of Pilgrim’s Blood Industry Executive Advisory Panel and provides Pilgrim extensive knowledge of the blood services industry and keen insight into the operational concerns facing the industry and provides proven and practical recommendations to apply to Pilgrim’s product strategies. |
 |
Dr. Johan van der Does is a member of Pilgrim’s Blood Industry Executive Advisory Panel and provides insight into industry issues and helps the company leverage its industry experience to build key relationships with other top Blood organizations. Because of Dr. van der Does’ extensive experience with the European Blood Community, he aids Pilgrim in the development of their European strategy for blood services. |
 |
Dr. Cameron Durrant serves as one of Pilgrim’s pharmaceutical and bio-tech industry expert and provides advice on go-to-market strategies and account penetration. Dr. Durrant brings with him 28 years of experience in the medical, healthcare and pharmaceutical sectors. He is an experienced entrepreneur. As a medically-trained MBA, with an international commercial, marketing, sales management, business development and a medical background, he brings to Pilgrim global and US commercial experience, coupled with R&D, company financing and business development experience. More Information |
 |
Bryan Morton serves as one of Pilgrim’s medical device industry experts and provides advice on go-to-market strategies and account penetration. Bryan has lived and worked in the UK, USA, Australia and Belgium and brings a rich knowledge of pharmaceuticals and medical devices to this advisory role. |